Non-Alcoholic Fatty Liver Disease
A Practical Guide
Herausgegeben von Farrell, Geoffrey C.; McCullough, Arthur J.; Day, Christopher P.
Non-Alcoholic Fatty Liver Disease
A Practical Guide
Herausgegeben von Farrell, Geoffrey C.; McCullough, Arthur J.; Day, Christopher P.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Do you have patients referred to you suffering from NAFLD? Are you looking for an expert guide to the latest in clinical management?
If so, this is the book for you, providing an expert and comprehensive analysis of NAFLD: what it is, why it happens, who is likely to suffer from it, and how to decide on the best management options for your patients.
This book focuses clearly on providing first-rate clinical guidance as to the assessment, diagnosis and treatment of patients in the clinical setting, based wherever possible on the latest evidence and scientific understanding of disease…mehr
- Autoimmune Liver Disease179,99 €
- Roger WilliamsClinical Dilemmas in Non-Alcoholic Fatty Liver Disease95,99 €
- The Pancreas360,99 €
- John M. InadomiYamada's Handbook of Gastroenterology106,99 €
- The Liver in Systemic Disease142,99 €
- Gary C. KanelPathology of Liver Diseases295,99 €
- Samuel S. LeeCirrhosis184,99 €
-
-
-
Are you looking for an expert guide to the latest in clinical management?
If so, this is the book for you, providing an expert and comprehensive analysis of NAFLD: what it is, why it happens, who is likely to suffer from it, and how to decide on the best management options for your patients.
This book focuses clearly on providing first-rate clinical guidance as to the assessment, diagnosis and treatment of patients in the clinical setting, based wherever possible on the latest evidence and scientific understanding of disease mechanisms. With each chapter fully revised and updated with the very latest in AASLD, EASL and Asia-Pacific guidelines, this second edition provides:
Four brand new chapters, including "NAFLD and cardiovascular risk factors" and "Non-invasive methods to determine severity of NAFLD/ NASH"
A clear overview on the causative mechanisms of NAFLD
Self-assessment via key points and multiple-choice questions throughout
The very latest in clinical drug trials
Analysis of NAFLD in relation to obesity, diabetes, high cholesterol and liver cancer
A consideration of NAFLD importance in Asia (particularly including Japan and China) and South America, as well as Europe and North America
NAFLD is a serious condition that is increasing in prevalence globally from year to year. Non-Alcoholic Fatty Liver Disease: A Practical Guide, is essential reading for all hepatologists and health professionals managing patients who have this condition.
- Produktdetails
- Verlag: Wiley & Sons
- Artikelnr. des Verlages: 14567317000
- 1. Auflage
- Seitenzahl: 328
- Erscheinungstermin: 29. April 2013
- Englisch
- Abmessung: 254mm x 192mm x 22mm
- Gewicht: 894g
- ISBN-13: 9780470673171
- ISBN-10: 0470673176
- Artikelnr.: 36900291
- Verlag: Wiley & Sons
- Artikelnr. des Verlages: 14567317000
- 1. Auflage
- Seitenzahl: 328
- Erscheinungstermin: 29. April 2013
- Englisch
- Abmessung: 254mm x 192mm x 22mm
- Gewicht: 894g
- ISBN-13: 9780470673171
- ISBN-10: 0470673176
- Artikelnr.: 36900291
vii 1 What is non-alcoholic fatty liver disease (NAFLD)
and why is it important? 1 Geoffrey C. Farrell
Arthur J. McCullough
and Christopher P. Day 2 NAFLD in the community
17 Leon A. Adams 3 Pathology of NAFLD
27 Elizabeth M. Brunt and David E. Kleiner 4 The natural history of NAFLD
37 Paul Angulo 5 Emerging concepts on the pathogenesis of non-alcoholic steatohepatitis (NASH)
46 Isabelle A. Leclercq 6 Diabetes and NAFLD: why is the connection important? 62 Elisabetta Bugianesi 7 NAFLD and cardiovascular risk factors: implications for vascular disease
71 Giovanni Targher 8 A primary care perspective of fatty liver: diagnosis
management
prescribing
and when to refer
84 Shivakumar Chitturi and Geoffrey C. Farrell 9 Imaging of NAFLD
93 Takeshi Yokoo
An Tang
and Claude B. Sirlin 10 Non-invasive methods to determine the severity of NAFLD and NASH
112 Vincent Wai-Sun Wong and Henry Lik-Yuen Chan 11 Fatigue
quality of life
and psychosocial issues for people with NAFLD
122 Julia L. Newton and James Frith 12 Physical activity and cardiovascular fi tness in patients with NAFLD: clinical importance and therapeutic implications
132 Ingrid J. Hickman
Graeme A. Macdonald
and Nuala M. Byrne 13 NAFLD
obesity
and bariatric surgery
149 Philippe Mathurin 14 Genetic predisposition to NAFLD and NASH: implications for pathogenesis
diagnosis
prevention
and management
157 Quentin M. Anstee
Ann K. Daly
and Christopher P. Day 15 NAFLD in children
171 Ariel E. Feldstein 16 The pointy end of the NAFLD iceberg: cirrhosis
portal hypertension
and liver failure
182 Jonathon W. Schwake
Dawn M. Torres
and Stephen A. Harrison 17 Non-alcoholic fatty liver disease
hepatocellular cancer
and other cancers
192 Janine Graham and Helen L. Reeves 18 NAFLD in Chinese and South Asian people
206 Jia-Horng Kao
Deepak Amarapurkar
and Jian-Gao Fan 19 Non-alcoholic fatty liver disease in Japan
217 Takeshi Okanoue
Kohichiroh Yasui
and Yoshito Itoh 20 Non-alcoholic fatty liver disease in South America and Hispanic people
228 Helma Pinchemel Cotrim and Carla Daltro 21 Alcohol in non-alcoholic fatty liver disease: an oxymoron or a new standard of care?
234 Achuthan Sourianarayanane
Srinivasan Dasarathy
and Arthur J. McCullough 22 Dietary factors in the pathogenesis and care of patients with fatty liver disease
248 Giulio Marchesini
Rebecca Marzocchi
Anna S. Sasdelli
Cristiana Andruccioli
and Silvia Di Domizio 23 Metabolic factors and steatosis in patients with hepatitis B and C
260 Francesco Negro 24 Drug therapy for NASH: insulin-sensitizing agents (metformin and thiazolidinediones)
271 Mohammad S. Siddiqui and Arun J. Sanyal 25 Hepatoprotectants against fatty liver disease: antioxidants
ursodeoxycholic acid
and herbal medicines
284 Anne Catherine Bürgi and Jean-François Dufour 26 Lipid modifiers and NASH: statins
ezetimibe
fibrates
and other agents
293 Giovanni Musso
Federica Molinaro
Elena Paschetta
Roberto Gambino
and Maurizio Cassader Index
308 Color plate section facing p86
vii 1 What is non-alcoholic fatty liver disease (NAFLD)
and why is it important? 1 Geoffrey C. Farrell
Arthur J. McCullough
and Christopher P. Day 2 NAFLD in the community
17 Leon A. Adams 3 Pathology of NAFLD
27 Elizabeth M. Brunt and David E. Kleiner 4 The natural history of NAFLD
37 Paul Angulo 5 Emerging concepts on the pathogenesis of non-alcoholic steatohepatitis (NASH)
46 Isabelle A. Leclercq 6 Diabetes and NAFLD: why is the connection important? 62 Elisabetta Bugianesi 7 NAFLD and cardiovascular risk factors: implications for vascular disease
71 Giovanni Targher 8 A primary care perspective of fatty liver: diagnosis
management
prescribing
and when to refer
84 Shivakumar Chitturi and Geoffrey C. Farrell 9 Imaging of NAFLD
93 Takeshi Yokoo
An Tang
and Claude B. Sirlin 10 Non-invasive methods to determine the severity of NAFLD and NASH
112 Vincent Wai-Sun Wong and Henry Lik-Yuen Chan 11 Fatigue
quality of life
and psychosocial issues for people with NAFLD
122 Julia L. Newton and James Frith 12 Physical activity and cardiovascular fi tness in patients with NAFLD: clinical importance and therapeutic implications
132 Ingrid J. Hickman
Graeme A. Macdonald
and Nuala M. Byrne 13 NAFLD
obesity
and bariatric surgery
149 Philippe Mathurin 14 Genetic predisposition to NAFLD and NASH: implications for pathogenesis
diagnosis
prevention
and management
157 Quentin M. Anstee
Ann K. Daly
and Christopher P. Day 15 NAFLD in children
171 Ariel E. Feldstein 16 The pointy end of the NAFLD iceberg: cirrhosis
portal hypertension
and liver failure
182 Jonathon W. Schwake
Dawn M. Torres
and Stephen A. Harrison 17 Non-alcoholic fatty liver disease
hepatocellular cancer
and other cancers
192 Janine Graham and Helen L. Reeves 18 NAFLD in Chinese and South Asian people
206 Jia-Horng Kao
Deepak Amarapurkar
and Jian-Gao Fan 19 Non-alcoholic fatty liver disease in Japan
217 Takeshi Okanoue
Kohichiroh Yasui
and Yoshito Itoh 20 Non-alcoholic fatty liver disease in South America and Hispanic people
228 Helma Pinchemel Cotrim and Carla Daltro 21 Alcohol in non-alcoholic fatty liver disease: an oxymoron or a new standard of care?
234 Achuthan Sourianarayanane
Srinivasan Dasarathy
and Arthur J. McCullough 22 Dietary factors in the pathogenesis and care of patients with fatty liver disease
248 Giulio Marchesini
Rebecca Marzocchi
Anna S. Sasdelli
Cristiana Andruccioli
and Silvia Di Domizio 23 Metabolic factors and steatosis in patients with hepatitis B and C
260 Francesco Negro 24 Drug therapy for NASH: insulin-sensitizing agents (metformin and thiazolidinediones)
271 Mohammad S. Siddiqui and Arun J. Sanyal 25 Hepatoprotectants against fatty liver disease: antioxidants
ursodeoxycholic acid
and herbal medicines
284 Anne Catherine Bürgi and Jean-François Dufour 26 Lipid modifiers and NASH: statins
ezetimibe
fibrates
and other agents
293 Giovanni Musso
Federica Molinaro
Elena Paschetta
Roberto Gambino
and Maurizio Cassader Index
308 Color plate section facing p86